Cargando…

Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease

PURPOSE: Health utilities are widely used in health economics as a measurement of an individual’s preference and show the value placed on different health states over a specific period. Thus, health utilities are used as a measure of the benefits of health interventions in terms of quality-adjusted...

Descripción completa

Detalles Bibliográficos
Autores principales: Miravitlles, Marc, Huerta, Alicia, Valle, Manuel, García-Sidro, Patricia, Forné, Carles, Crespo, Carlos, López-Campos, José Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337593/
https://www.ncbi.nlm.nih.gov/pubmed/25733826
http://dx.doi.org/10.2147/COPD.S76397
_version_ 1782481089601732608
author Miravitlles, Marc
Huerta, Alicia
Valle, Manuel
García-Sidro, Patricia
Forné, Carles
Crespo, Carlos
López-Campos, José Luis
author_facet Miravitlles, Marc
Huerta, Alicia
Valle, Manuel
García-Sidro, Patricia
Forné, Carles
Crespo, Carlos
López-Campos, José Luis
author_sort Miravitlles, Marc
collection PubMed
description PURPOSE: Health utilities are widely used in health economics as a measurement of an individual’s preference and show the value placed on different health states over a specific period. Thus, health utilities are used as a measure of the benefits of health interventions in terms of quality-adjusted life years. This study aimed to determine the demographic and clinical variables significantly associated with health utilities for chronic obstructive pulmonary disease (COPD) patients. PATIENTS AND METHODS: This was a multicenter, observational, cross-sectional study conducted between October 2012 and April 2013. Patients were aged ≥40 years, with spirometrically confirmed COPD. Utility values were derived from the preference-based generic questionnaire EQ-5D-3L applying weighted Spanish societal preferences. Demographic and clinical variables associated with utilities were assessed by univariate and multivariate linear regression models. RESULTS: Three hundred and forty-six patients were included, of whom 85.5% were male. The mean age was 67.9 (standard deviation [SD] =9.7) years and the mean forced expiratory volume in 1 second (%) was 46.2% (SD =15.5%); 80.3% were former smokers, and the mean smoking history was 54.2 (SD =33.2) pack-years. Median utilities (interquartile range) were 0.81 (0.26) with a mean value of 0.73 (SD =0.29); 22% of patients had a utility value of 1 (ceiling effect) and 3.2% had a utility value lower than 0. The factors associated with utilities in the multivariate analysis were sex (beta =-0.084, 95% confidence interval [CI]: −0.154; -0.013 for females), number of exacerbations the previous year (−0.027, 95% CI: −0.044; -0.010), and modified Medical Research Council Dyspnea Scale (mMRC) score (−0.123 [95% CI: −0.185; −0.061], −0.231 [95% CI: −0.301; −0.161], and −0.559 [95% CI: −0.660; −0.458] for mMRC scores 2, 3, and 4 versus 1), all P<0.05. CONCLUSION: Multivariate analysis showed that female sex, frequent exacerbations, and an increased level of dyspnea were the main factors associated with reduced utility values in patients with COPD.
format Online
Article
Text
id pubmed-4337593
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-43375932015-03-02 Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease Miravitlles, Marc Huerta, Alicia Valle, Manuel García-Sidro, Patricia Forné, Carles Crespo, Carlos López-Campos, José Luis Int J Chron Obstruct Pulmon Dis Original Research PURPOSE: Health utilities are widely used in health economics as a measurement of an individual’s preference and show the value placed on different health states over a specific period. Thus, health utilities are used as a measure of the benefits of health interventions in terms of quality-adjusted life years. This study aimed to determine the demographic and clinical variables significantly associated with health utilities for chronic obstructive pulmonary disease (COPD) patients. PATIENTS AND METHODS: This was a multicenter, observational, cross-sectional study conducted between October 2012 and April 2013. Patients were aged ≥40 years, with spirometrically confirmed COPD. Utility values were derived from the preference-based generic questionnaire EQ-5D-3L applying weighted Spanish societal preferences. Demographic and clinical variables associated with utilities were assessed by univariate and multivariate linear regression models. RESULTS: Three hundred and forty-six patients were included, of whom 85.5% were male. The mean age was 67.9 (standard deviation [SD] =9.7) years and the mean forced expiratory volume in 1 second (%) was 46.2% (SD =15.5%); 80.3% were former smokers, and the mean smoking history was 54.2 (SD =33.2) pack-years. Median utilities (interquartile range) were 0.81 (0.26) with a mean value of 0.73 (SD =0.29); 22% of patients had a utility value of 1 (ceiling effect) and 3.2% had a utility value lower than 0. The factors associated with utilities in the multivariate analysis were sex (beta =-0.084, 95% confidence interval [CI]: −0.154; -0.013 for females), number of exacerbations the previous year (−0.027, 95% CI: −0.044; -0.010), and modified Medical Research Council Dyspnea Scale (mMRC) score (−0.123 [95% CI: −0.185; −0.061], −0.231 [95% CI: −0.301; −0.161], and −0.559 [95% CI: −0.660; −0.458] for mMRC scores 2, 3, and 4 versus 1), all P<0.05. CONCLUSION: Multivariate analysis showed that female sex, frequent exacerbations, and an increased level of dyspnea were the main factors associated with reduced utility values in patients with COPD. Dove Medical Press 2015-02-16 /pmc/articles/PMC4337593/ /pubmed/25733826 http://dx.doi.org/10.2147/COPD.S76397 Text en © 2015 Miravitlles et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Miravitlles, Marc
Huerta, Alicia
Valle, Manuel
García-Sidro, Patricia
Forné, Carles
Crespo, Carlos
López-Campos, José Luis
Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease
title Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease
title_full Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease
title_fullStr Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease
title_full_unstemmed Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease
title_short Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease
title_sort clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337593/
https://www.ncbi.nlm.nih.gov/pubmed/25733826
http://dx.doi.org/10.2147/COPD.S76397
work_keys_str_mv AT miravitllesmarc clinicalvariablesimpactingontheestimationofutilitiesinchronicobstructivepulmonarydisease
AT huertaalicia clinicalvariablesimpactingontheestimationofutilitiesinchronicobstructivepulmonarydisease
AT vallemanuel clinicalvariablesimpactingontheestimationofutilitiesinchronicobstructivepulmonarydisease
AT garciasidropatricia clinicalvariablesimpactingontheestimationofutilitiesinchronicobstructivepulmonarydisease
AT fornecarles clinicalvariablesimpactingontheestimationofutilitiesinchronicobstructivepulmonarydisease
AT crespocarlos clinicalvariablesimpactingontheestimationofutilitiesinchronicobstructivepulmonarydisease
AT lopezcamposjoseluis clinicalvariablesimpactingontheestimationofutilitiesinchronicobstructivepulmonarydisease